Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
-
Shares outstanding
-
9,036,176
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
20,649,684
-
Shares change
-
+585,223
-
Total reported value, excl. options
-
$15,057,860
-
Value change
-
+$402,638
-
Number of buys
-
5
-
Number of sells
-
11
-
Price
-
$0.7292
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) as of Q1 2024
As of 31 Mar 2024 Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) had 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,649,684 shares of stock of the company.
Largest 10 holders included Kynam Capital Management, LP, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, FIL Ltd, MILLENNIUM MANAGEMENT LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., RENAISSANCE TECHNOLOGIES LLC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, and HSG Holding Ltd.
This table shows 20 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.